1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A 2

This publication has 6 references indexed in Scilit:

• The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2
  Bioorganic & Medicinal Chemistry Letters, 2001
• Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target
  Current Opinion in Pharmacology, 2001
• N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2
  Bioorganic & Medicinal Chemistry Letters, 2000
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000
• Current and future treatment of hyperlipidemia: the role of statins
  The American Journal of Cardiology, 1998
• Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density Lipoproteins
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996